Daniel Raymond

Direktor/Vorstandsmitglied bei Kv1.3 Therapeutics, Inc.

Health Technology

Aktive Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Craig Philips	M	64	Kv1.3 Therapeutics, Inc. Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA.	-
Shawn Iadonato	M	54	Kv1.3 Therapeutics, Inc. Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA.	-
Michael O. Banks	M	64	Kv1.3 Therapeutics, Inc. Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA.	-
Lucien Fouke	M	-	Kv1.3 Therapeutics, Inc. Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA.	-
Gavin Jancke	M	-	Kv1.3 Therapeutics, Inc. Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA.	-